Search results for "Mort"

showing 10 items of 1955 documents

Creación de un instrumento de decisión objetivo para la indicación de tratamiento quirúrgico vs conservador en la fractura de cadera

2022

La mortalidad tras la fractura de cadera es elevada y conocer en el ingreso el riesgo de mortalidad podría ser de utilidad para ajustar la necesidad de cuidados pre y perioperatorios, ayudar a la toma de decisiones y permitir el ajuste de riesgo en auditorías. En el Hospital de la Ribera (Alzira) hemos creado un modelo que tras el ingreso por la fractura de cadera mida el riesgo de mortalidad a los 30 (Alzira Hip Fracture Score: AHFS-30) y 180 días (AHFS-180). Métodos: Se incluyeron 701 pacientes mayores de 69 años, ingresados de forma consecutiva por cualquier tipo de fractura de cadera. Se recogieron las variables asociadas a mortalidad en estudios previos. Se realizó una regresión logíst…

fractura de caderaUNESCO::CIENCIAS MÉDICASmortalidadvariables predictivas
researchProduct

Il Fast Track nelle fratture di femore può davvero favorire risultati clinici migliori?

2016

Le attuali linee guida raccomandano di effettuare il trattamento chirurgico di stabilizzazione o sosti- tuzione protesica entro 24-48 ore dall’accesso ospedaliero, al ne di migliorare il risultato funziona- le, ridurre il rischio di mortalità, la degenza ospedaliera e le complicazioni post-operatorie. Tuttavia, la mancanza di studi randomizzati rappresenta un importantissimo limite scienti co dal momento che ad oggi la migliore evidenza scienti ca sul timing chirurgico nelle fratture di collo femore si basa esclusivamente su studi prospettici e retrospettivi. In questo articolo, viene descritto il percorso ospedaliero per il trattamento delle fratture del collo del femore nel paziente anzia…

fratture femore fast-track fratture over 65 fratture femore mortalità fratture femore trattamento chirurgico precoce 48 ore frattureSettore MED/33 - Malattie Apparato Locomotore
researchProduct

Giudicato tributario, oggetto del giudizio di ottemperanza e impugnazione della sentenza

2020

La sentenza emessa in ottemperanza è limitata, quanto all’oggetto, all’ambito della sentenza da ottemperare ed è impugnabile solo con ricorso per cassazione ai sensi dell’art. 70 del D.lgs. n. 546/92 e in coerenza con l’art. 111 della Cost. The judgment given in compliance, limited, as to the object, to the scope of the judgment to be complied with, is subject to appeal only by appeal to the Supreme Court, as provided by art. 70, D.lgs. n. 546/92 and pursuant to art. 111 Cost.

giudizio di ottemperanza oggetto del giudizio iscrizione ipotecaria impugnazionejudgment of compliance object of the judgment registration of a mortgage appealSettore IUS/12 - Diritto Tributario
researchProduct

Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

2010

Abstract The clinical relevance of angiopoietin-2 (Ang2) in chronic lymphocytic leukemia (CLL) was previously suggested by the association between high Ang2, and shorter progression-free survival reported in small series of patients. Here, we evaluated Ang2 glycoprotein levels in plasma samples collected from a multicentric cohort of CLL patients (n = 316) using an enzyme-linked immunosorbent assay method, and we investigated its prognostic role in relation to time to first treatment (TTFT) and overall survival. Based on a cutoff equal to 2459 pg/mL, we divided our cohort in 2 subsets (high and low Ang2) composing 100 (31.6%) and 216 (68.4%) patients, respectively. High Ang2 was predictive …

glycoproteinMaleTime FactorsZAP-70Chronic lymphocytic leukemiavascular endothelial growth factor aBiochemistryGastroenterologyimmunoglobulin heavy chainsAdult Aged Aged; 80 and over Angiopoietin-2; analysis/blood Blood Chemical Analysis Female Humans Leukemia; Lymphocytic; Chronic; B-Cell; blood/diagnosis/mortality/therapy Male Middle Aged Neoadjuvant Therapy Prognosis Survival Analysis Time Factors Tumor Markers; Biological; bloodBlood plasma80 and overChronicTumor MarkersAged 80 and overLeukemiaHematologyHazard ratioprotein kinaseHematologyanalysis/bloodMiddle Agedchronic b-cell leukemiasPrognosisLymphocyticNeoadjuvant TherapyLeukemiaCohortFemaleAdultmedicine.medical_specialtyImmunologyangiopoietins chronic b-cell leukemias chronic lymphocytic leukemia plasma vascular endothelial growth factor a cd38 enzyme-linked immunosorbent assay glycoprotein immunoglobulin heavy chains protein kinaseNOcd38Angiopoietin-2bloodInternal medicinemedicineBiomarkers Tumorchronic lymphocytic leukemia angiopoietin-2.Humansbeta(2)-microglobulinplasmaSurvival analysisblood/diagnosis/mortality/therapyAgedbusiness.industryB-CellCell BiologyBiologicalmedicine.diseaseLeukemia Lymphocytic Chronic B-CellSurvival AnalysisConfidence intervalImmunologychronic lymphocytic leukemiaangiopoietin-2enzyme-linked immunosorbent assaybusinessCLL; angiopoietin-2; beta(2)-microglobulin; ZAP-70; CD38Settore MED/15 - Malattie del SangueangiopoietinsBlood Chemical AnalysisCLLCD38Blood Chemical Analysis; Angiopoietin-2; Humans; Neoadjuvant Therapy; Prognosis; Aged; Aged 80 and over; Leukemia Lymphocytic Chronic B-Cell; Adult; Middle Aged; Tumor Markers Biological; Time Factors; Female; Male; Survival Analysis
researchProduct

Histoire de la peine de mort en France (1789-1981)

2006

L’abolition de la peine de mort dans la législation pénale française date de 1981, concluant un long combat qui a duré près de deux siècles, depuis le projet de Code pénal soumis en 1791 à l’Assemblée constituante jusqu’à la loi du 9 octobre 1981 portant abolition de la peine de mort.A l’occasion du 25e anniversaire de l’abolition, le site web Criminocorpus a mis en ligne, le 10 octobre 2006 :- Les textes (1791, 1908 et 1981)La retranscription intégrale des trois débats parlementaires ayant eu lieu sur ce thème.- Un article de synthèse : La peine de mort en France : Deux siècles pour une abolition. 1791-1981- Une exposition virtuelleLe parcours complet est composé de plus de deux cents page…

guillotinepeine de mort[SHS.HIST] Humanities and Social Sciences/HistoryabolitionBadinterexposition virtuelle
researchProduct

STUDIO ETNOARCHEOMETRICO DI MALTE AEREE A LEGANTE GESSOSO NELL’AREA DELLE MADONIE (SICILIA SETTENTRIONALE)

2010

The Madonie Regional Park, which covers an area of about 400 square kilometres, is an ideal context where environment and man activities are still mixed harmoniously. In the last years a variety of ethno-archaeometric investigations have been carried out in order to study various aspects of the "material culture" of this territory. In particular, the research was focused on the production of majolica which have had a great importance since the early decades of the 16th century thanks to the geolithological features of the Madonie area, particularly rich in clayey raw material. The traditional building techniques of the Madonie which involve several typologies of building materials (used for…

gypsum-based mortars traditional kilns Northern SicilySettore GEO/09 -Georis. Miner.e Appl.Mineral.-Petrogr. per l'Ambi.ed i B.Cult.
researchProduct

Healthy and active pre-retirement and retirement ages: elderly inequality in Latvia

2019

Pre-retirement and senior population groups are more affected by activity limitations, unemployment and bad perceived health than population in active ages. Data for Latvia and other EU countries demonstrate a warning situation – socio-economic inequalities among elderly are not diminishing as fast as was expected. The aim of the paper is to analyse healthy and active life in pre-retirement and retirement ages to detect changes and inequalities complying with active ageing and public health. Analysis is based on Population Census and SILC data on national, regional and smaller territorial level. Regression models are used to study causal links and relations between the underlying social and…

healthy life yearsactive ageingelderly inequality:SOCIAL SCIENCES::Business and economics [Research Subject Categories]mortality
researchProduct

Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study

2021

Background: Heart failure (HF) is a multifactorial syndrome with pathophysiological complexities still not fully understood. Higher mean platelet volume (MPV), a potential marker of platelet activation, and high concentrations of parathyroid hormone (PTH) have been implicated in the pathogenesis of HF.Aim: This study aims to investigate sex-specifically the association between PTH concentrations and platelet indices in phenotypes of HF.Methods and Results: PTH and platelet indices (MPV and platelet count) were available in 1,896 participants from the MyoVasc study in Mainz, Germany. Multivariable linear regression models, adjusted for age, sex, season, vitamin D status, cardiovascular risk …

heart failure with preserved ejection fractionBIOMARKERmedicine.medical_specialtyPATHOPHYSIOLOGYheart failureParathyroid hormoneCardiovascular Medicine030204 cardiovascular system & hematologyMPVDISEASE03 medical and health sciences0302 clinical medicineInternal medicineMANAGEMENTVitamin D and neurologymedicineDiseases of the circulatory (Cardiovascular) systemparathyroid hormoneheart failure with reduced ejection fractionPlatelet030212 general & internal medicinePlatelet activationMean platelet volumeVITAMIN-DOriginal ResearchRISKEjection fractionbusiness.industryMORTALITYplatelet countmedicine.diseaseDYSFUNCTIONEndocrinologyRC666-701Heart failureCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinessFrontiers in Cardiovascular Medicine
researchProduct

Right Ventricular Dysfunction Staging System for Mortality Risk Stratification in Heart Failure with Preserved Ejection Fraction

2020

Right ventricular dysfunction (RVD) parameters are increasingly important features in heart failure with preserved ejection fraction (HFpEF). We sought to evaluate the prognostic impact of a progressive RVD staging system by combining the tricuspid annular plane systolic excursion (TAPSE) to pulmonary artery systolic pressure (TAPSE/PASP) ratio with functional tricuspid regurgitation (TR) severity. We prospectively included 1355 consecutive HFpEF patients discharged for acute heart failure (HF). Of them, in 471 (34.7%) patients, PASP could not be accurately measured, leaving the final sample size to be 884 patients. Patients were categorized as Stage 1: TAPSE/PASP &ge

heart failure with preserved ejection fractionmedicine.medical_specialtylcsh:Medicinerisk stratification030204 cardiovascular system & hematologyArticle03 medical and health sciences0302 clinical medicineInternal medicinemedicine.arterymedicine030212 general & internal medicineStage (cooking)right ventricularStaging systemRisk stratificationRight ventricularbusiness.industryMortality ratelcsh:RGeneral Medicinemedicine.diseaseBlood pressureHeart failure with preserved ejection fractionHeart failurePulmonary arteryRisk stratificationCardiologybusinessHeart failure with preserved ejection fraction
researchProduct

O potrzebie nowego uregulowania odwróconej hipoteki

2017

Głównym celem pracy jest zbadanie polskiego stanu prawnego dotyczącego instytucji odwróconej hipoteki oraz analiza stosowalności i skuteczności przyjętych regulacji. Na gruncie tego opracowania podjęta została próba udowodnienia tezy, że instytucja odwróconej hipoteki jest potrzebna, lecz aktualny stan prawny jest uregulowaniem niepełnym i nieskutecznym, a ponadto, że istnieje potrzeba nowego unormowania obu modeli odwróconej hipoteki. Aby udowodnić postawioną tezę, konieczne było przeanalizowanie procesów legislacyjnych ustawy o odwróconym kredycie hipotecznym oraz ustawy o dożywotnim świadczeniu pieniężnym, która to ostatecznie nie weszła w życie. Wskazanie uchybień i niedokładności w tre…

home reversionlife annuity.reverse mortgagerentadożywocie.odwrócona hipotekapensionZeszyty Naukowe Instytutu Administracji Akademii im. Jana Długosza w Częstochowie, Gubernaculum et Administratio, Historia, Prawo, Administracja
researchProduct